Xiaojing Wang

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

Suhas Vasaikar, Chen Huang, Xiaojing Wang et al. · Cell · 2019 · 801 citations · Full text

Oncology, Medicine, Colorectal Cancer +7

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer

Jun Liang, Robert A. Blake, Jae H. Chang et al. · Journal of Medicinal Chemistry · 2021 · 130 citations · Full text

Patterns of Failure in Advanced Stage Diffuse Large B-Cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidative Radiation Therapy

Zheng Shi, Satya Das, Derick Okwan‐Duodu et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 85 citations

Consolidative Radiation Therapy, Lymphoid Neoplasia, Hematological Malignancy +11

Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design

Xiaojing Wang, Steven Magnuson, Rich Pastor et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 67 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Property-based Drug Design +10

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 64 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11